Arizona Pulmonary Specialists

Arizona Pulmonary Specialists provides comprehensive outpatient and inpatient care for patients with lung diseases, infectious diseases, and rheumatologic disorders. The group offers advanced diagnostics and treatments including state-of-the-art procedures and participates in clinical research. It operates accredited specialty programs such as a PHA-accredited pulmonary hypertension center.

No proprietary drug or device development pipeline exists.

Clinical results are those of standard-of-care medical practice rather than investigational product trials.

The group has been active since at least December of 1996.

It serves the Phoenix and Scottsdale areas in Arizona through multiple office locations.

Key services include diagnosis/treatment of asthma, COPD/emphysema/chronic bronchitis, pneumonia/infectious lung disease, sleep apnea management, pulmonary hypertension care, interstitial lung disease/fibrosis management, rheumatology-related lung issues.

The team includes board-certified pulmonologists and nurse practitioners with subspecialty expertise in critical care medicine and infectious disease.

Revenue estimated at $18.1 million annually with approximately ~50 employees.

No evidence of acquisition or public trading status.

Notable for its role as an accredited center for pulmonary hypertension by the Pulmonary Hypertension Association.